- Home
- GRFS vs LLYVA Comparison
GRFS vs LLYVA Comparison
Compare GRFS & LLYVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | GRFS | LLYVA |
|---|---|---|
| Founded | 1940 | 1991 |
| Country | Spain | United States |
| Employees | 25247 | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Broadcasting |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.8B | 8.2B |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | GRFS | LLYVA |
|---|---|---|
| Price | $7.84 | $90.30 |
| Analyst Decision | Hold | |
| Analyst Count | 2 | 0 |
| Target Price | ★ $10.15 | N/A |
| AVG Volume (30 Days) | ★ 682.6K | 144.6K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | ★ 1.79% | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $5.33 | N/A |
| Revenue Next Year | $6.50 | $9.89 |
| P/E Ratio | $18.67 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $6.19 | $59.70 |
| 52 Week High | $11.14 | $99.63 |
Technical Indicators
Market Signals| Indicator | GRFS | LLYVA |
|---|---|---|
| Relative Strength Index (RSI) | 27.72 | 46.00 |
| Support Level | $7.64 | $78.00 |
| Resistance Level | $9.11 | $91.50 |
| Average True Range (ATR) | 0.29 | 3.49 |
| MACD | -0.12 | -0.82 |
| Stochastic Oscillator | 2.99 | 2.98 |
Price Performance
Historical ComparisonAbout GRFS Grifols S.A.
Grifols SA one of is global specialty plasma therapeutics companies developing, manufacturing and distributing a broad range of biological medicines based on plasma derived proteins. Plasma derivatives are proteins found in human plasma, which once isolated and purified, have therapeutic value. These protein-based therapies extend and enhance the lives of individuals who suffer from chronic and acute, often life-threatening, conditions, including primary and secondary immunological deficiencies, Chronic Inflammatory Demyelinating Polyneuropathy, immune-mediated ITP. Products and services are used to diagnose and treat patients with hemophilia, immune deficiencies, infectious diseases and a range of other medical conditions. Majority of revenue is from USA.
About LLYVA Liberty Media Corporation Series A Liberty Live
Liberty Live Holdings Inc focuses on live entertainment investments. The company maintains a substantial ownership position in Live Nation Entertainment, the primary international promoter of concerts, events, and ticketing through platforms like Ticketmaster, alongside sponsorship and hospitality services via QuintEvents.